• Return to Headlines

Uptrend Call Working As Supernus Pharmac Stock Rises 31.0% (SUPN)

By Amy Schwartz

SmarTrend identified an Uptrend for Supernus Pharmac (NASDAQ:SUPN) on March 6th, 2018 at $41.25. In approximately 3 months, Supernus Pharmac has returned 31.03% as of today's recent price of $54.05.

In the past 52 weeks, shares of Supernus Pharmac have traded between a low of $33.30 and a high of $59.05 and are now at $54.15, which is 63% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 1.1%.

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Supernus Pharmac shares.

Log in and add Supernus Pharmac (SUPN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights supernus pharmac

Ticker(s): SUPN